Tugasan, Janice G.
HRN: 09-29-12 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2023
CEFUROXIME 1.5GM (VIAL)
08/10/2023
08/17/2023
IV
1.5g
Q8
CAP-MR
Waiting Final Action